Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL557P (RNA, 7SL, cytoplasmic 557, pseudogene) is a noncoding pseudogene in the human genome. It is related to the 7SL RNA, the RNA component of the signal recognition particle (SRP) complex, which is essential for co-translational protein targeting to the endoplasmic reticulum. However, RN7SL557P itself is a nonfunctional segment likely derived from reverse transcription and insertion of 7SL RNA into the genome. Pseudogenes such as RN7SL557P may occasionally have regulatory effects, such as acting as competing endogenous RNAs or producing small interfering RNAs, but there is no evidence RN7SL557P has such a function. Most 7SL-related pseudogenes are considered nonfunctional genetic elements and are not implicated as direct disease drivers or therapeutic targets.
None. As RN7SL557P is a noncoding pseudogene, there is no mechanism of action related to pharmacological intervention
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 557, pseudogene (RN7SL557P).